RecruitingNot ApplicableNCT06531473

Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures

Laser Outcomes Associated With HoLEP Procedures


Sponsor

Northwestern University

Enrollment

300 participants

Start Date

Mar 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2j 50hz. These settings are conventional settings, but there is no literature to prove optimal laser settings. The investigators hypothesizes that utilization of higher laser settings may be associated with a clinically significant (defined as \> 10%) decrease in procedural time without any detrimental postoperative outcomes, and a utilization of lower laser settings may be associated with a clinically significant (defined as \>10%) reduction in postoperative irritative voiding symptoms without any detrimental postoperative outcomes.


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called HoLEP for people with prostate obstruction and urologic diseases. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years to 89 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHoLEP

Patients will be randomized to one of the laser energy groups day of surgery.


Locations(1)

Northwestern Medicine

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06531473


Related Trials